Detalhe da pesquisa
1.
Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies.
Cell
; 178(1): 216-228.e21, 2019 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31204103
2.
Assessment of precision in growth inhibition assay (GIA) using human anti-PfRH5 antibodies.
Malar J
; 22(1): 159, 2023 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37208733
3.
One-step design of a stable variant of the malaria invasion protein RH5 for use as a vaccine immunogen.
Proc Natl Acad Sci U S A
; 114(5): 998-1002, 2017 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-28096331
4.
Harmonization study between three laboratories for expression of malaria vaccine clinical trial IgG antibody ELISA data in µg/mL.
Malar J
; 18(1): 300, 2019 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31477111
5.
Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01.
J Infect Dis
; 213(11): 1743-51, 2016 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26908756
6.
Evaluation of the precision of the Plasmodium knowlesi growth inhibition assay for Plasmodium vivax Duffy-binding protein-based malaria vaccine development.
Vaccine
; 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38704253
7.
PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial.
NPJ Vaccines
; 9(1): 10, 2024 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38184681
8.
A systematic analysis of the human immune response to Plasmodium vivax.
J Clin Invest
; 133(20)2023 10 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37616070
9.
Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine.
JCI Insight
; 8(2)2023 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36692019
10.
Analyses of human vaccine-specific circulating and bone marrow-resident B cell populations reveal benefit of delayed vaccine booster dosing with blood-stage malaria antigens.
Front Immunol
; 14: 1193079, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38299155
11.
Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults.
Med
; 4(10): 668-686.e7, 2023 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37572659
12.
Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection.
Sci Transl Med
; 15(704): eadf1782, 2023 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37437014
13.
RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting.
Front Cell Infect Microbiol
; 12: 1049065, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36605129
14.
Repeat controlled human malaria infection of healthy UK adults with blood-stage Plasmodium falciparum: Safety and parasite growth dynamics.
Front Immunol
; 13: 984323, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36072606
15.
Impact of a blood-stage vaccine on Plasmodium vivax malaria.
medRxiv
; 2022 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35664997
16.
Low Adenovirus Vaccine Doses Administered to Skin Using Microneedle Patches Induce Better Functional Antibody Immunogenicity as Compared to Systemic Injection.
Vaccines (Basel)
; 9(3)2021 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33810085
17.
Poor CD4+ T Cell Immunogenicity Limits Humoral Immunity to P. falciparum Transmission-Blocking Candidate Pfs25 in Humans.
Front Immunol
; 12: 732667, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34659219
18.
Identification and Immune Assessment of T Cell Epitopes in Five Plasmodium falciparum Blood Stage Antigens to Facilitate Vaccine Candidate Selection and Optimization.
Front Immunol
; 12: 690348, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34305923
19.
Antibodies from malaria-exposed Malians generally interact additively or synergistically with human vaccine-induced RH5 antibodies.
Cell Rep Med
; 2(7): 100326, 2021 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34337556
20.
Protein/AS01B vaccination elicits stronger, more Th2-skewed antigen-specific human T follicular helper cell responses than heterologous viral vectors.
Cell Rep Med
; 2(3): 100207, 2021 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33763653